tepoxalin

Term ID

CHEBI:76277

Synonyms

3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl]-N-hydroxy-N-methylpropanamide
5-(p-Chlorophenyl)-1-(p-methoxyphenyl)-N-methylpyrazole-3-propionohydroxamic acid
ORF 20485
ORF-20485
RWJ 20485
tepoxalin
tepoxalina
tepoxaline
tepoxaliume
Zubrin

Definition

A hydroxamic acid obtained by formal condensation of the carboxy group of 3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]propanoic acid with the amino group of N-methylhydroxylamine. It is used in veterinary medicine for the control of pain and inflammation caused by musculoskeletal disorders such as hip dysplasia and arthritis in dogs.

References

cas:103475-41-8
kegg.compound:C18362
kegg.drug:D06075
patent:WO2007022427
pubmed:16343292
pubmed:19161461
pubmed:19175721
pubmed:19552701
pubmed:19566476
pubmed:19624842
pubmed:20000343
pubmed:20807147
pubmed:21036634
pubmed:21062309
pubmed:21348304
pubmed:21497474
pubmed:21565533
pubmed:21569197
pubmed:21962280
pubmed:22091562
pubmed:22240988
pubmed:22287649
pubmed:22726277
pubmed:22986275
pubmed:23349526
pubmed:23718664
pubmed:23802664
pubmed:7652766
pubmed:9703407
reaxys:4334297
vsdb:1877
wikipedia.en:Tepoxalin

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from tepoxalin

Phenotype where environments contain tepoxalin

Phenotype modified by environments containing tepoxalin

Phenotype affecting tepoxalin

Human Disease Model